Company · CIK 2012593

# Rapport Therapeutics, Inc.

| CIK | [2012593](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002012593) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | RAPP (Nasdaq) |
| First annual or quarterly report | 2024-08-08 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-294170 | Shelf Effective | 2026-03-10 | 2026-03-10 | 1 |
| 333-288444 | Shelf Effective | 2025-07-01 | 2026-01-07 | 5 |
| 333-288445 | Shelf Effective | 2025-07-01 | 2025-07-09 | 2 |
| 333-279486 | IPO Final prospectus | 2024-05-17 | 2024-06-07 | 4 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-10 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/2012593/000119312526099421/0001193125-26-099421-index.htm) Shelf registered | 333-294170 | 0001193125-26-099421 |
| 2026-01-07 | [424B5](https://www.sec.gov/Archives/edgar/data/2012593/000119312526005482/0001193125-26-005482-index.htm) Shelf takedown | 333-288444 | 0001193125-26-005482 |
| 2025-09-10 | [424B5](https://www.sec.gov/Archives/edgar/data/2012593/000119312525200200/0001193125-25-200200-index.htm) Shelf takedown | 333-288444 | 0001193125-25-200200 |
| 2025-09-08 | [424B5](https://www.sec.gov/Archives/edgar/data/2012593/000119312525198453/0001193125-25-198453-index.htm) Shelf takedown | 333-288444 | 0001193125-25-198453 |
| 2025-07-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2012593/999999999525002211/9999999995-25-002211-index.htm) Declared effective | 333-288445 | 9999999995-25-002211 |
| 2025-07-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2012593/999999999525002210/9999999995-25-002210-index.htm) Declared effective | 333-288444 | 9999999995-25-002210 |
| 2025-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/2012593/000119312525153417/0001193125-25-153417-index.htm) Shelf registered | 333-288445 | 0001193125-25-153417 |
| 2025-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/2012593/000119312525153415/0001193125-25-153415-index.htm) Shelf registered | 333-288444 | 0001193125-25-153415 |
| 2024-06-07 | [424B4](https://www.sec.gov/Archives/edgar/data/2012593/000119312524157358/0001193125-24-157358-index.htm) Final prospectus | 333-279486 | 0001193125-24-157358 |
| 2024-06-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2012593/999999999524001768/9999999995-24-001768-index.htm) Declared effective | 333-279486 | 9999999995-24-001768 |
| 2024-06-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2012593/000119312524152294/0001193125-24-152294-index.htm) Amendment | 333-279486 | 0001193125-24-152294 |
| 2024-05-17 | [S-1](https://www.sec.gov/Archives/edgar/data/2012593/000119312524141704/0001193125-24-141704-index.htm) Registration filed | 333-279486 | 0001193125-24-141704 |
| 2024-03-27 | [DRS](https://www.sec.gov/Archives/edgar/data/2012593/000095012324003008/0000950123-24-003008-index.htm) Draft made public | 377-07153 | 0000950123-24-003008 |

[All filings of this company](https://equitycapital.markets/filings?cik=2012593) · [CSV](https://equitycapital.markets/filings.csv?cik=2012593)

---
Source page: https://equitycapital.markets/company/2012593 · Data: U.S. SEC EDGAR · CC BY 4.0